In March, anti-GMO groups across the US launched a last-ditch effort to halt the commercialization of AquaBounty's transgenic AquAdvantage salmon.
AquaBounty
The New York Times editorial board apparently has dec
ACSH relies on donors like you. If you enjoy our work, please contribute.
Make your tax-deductible gift today!
Popular articles
ACSH Podcasts
